Sabra Healthcare REIT (SBRA) to Release Quarterly Earnings on Monday

Key Points

• Sabra Healthcare REIT is expected to release its Q2 2025 earnings on August 4th, with analysts predicting earnings of $0.37 per share and revenue of $185.64 million.
• The firm recently announced a quarterly dividend of $0.30 per share, resulting in a yield of 6.59% and indicating a payout ratio of 203.39%.
• Scotiabank has upgraded Sabra Healthcare REIT's price target from $19.00 to $20.00, reflecting a "sector perform" rating based on the stock's recent performance.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) is expected to release its Q2 2025 earnings data after the market closes on Monday, August 4th. Analysts expect Sabra Healthcare REIT to post earnings of $0.37 per share and revenue of $185.64 million for the quarter. Sabra Healthcare REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. The business had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.35 EPS. On average, analysts expect Sabra Healthcare REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA traded down $0.24 during midday trading on Monday, hitting $17.98. The company had a trading volume of 2,372,621 shares, compared to its average volume of 2,184,828. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.22 and a quick ratio of 4.22. The company has a market cap of $4.28 billion, a price-to-earnings ratio of 30.47, a PEG ratio of 1.51 and a beta of 0.85. Sabra Healthcare REIT has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a fifty day moving average of $18.09 and a two-hundred day moving average of $17.47.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.67%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 203.39%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director directly owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Sabra Healthcare REIT stock. Focus Partners Wealth lifted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 11.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,146 shares of the real estate investment trust's stock after purchasing an additional 2,375 shares during the period. Focus Partners Wealth's holdings in Sabra Healthcare REIT were worth $404,000 as of its most recent filing with the Securities & Exchange Commission. 99.40% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Scotiabank raised their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $19.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.